v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive (Loss)/Income
Non-controlling interest in consolidated subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2022   57,655            
Balance, beginning of period at Dec. 31, 2022 $ 3,003,010 $ 58   $ 847,965 $ 2,248,948 $ (118) $ (95,321) $ 1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     224          
Equity withheld for employee taxes (in shares)   (72)            
Equity withheld for employee taxes (20,501)     (20,501)        
Stock-based compensation expense 34,265     34,265        
Exercise of stock options (in shares)   71            
Exercise of stock options 2,525     2,525        
Repurchase of common stock, including excise tax (in shares)   (30)            
Repurchase of common stock, including excise tax (8,510)       (8,510)      
Other comprehensive (loss) income 17,361           17,361  
Net income 102,292       102,292      
Balance, end of period (in shares) at Mar. 31, 2023   57,848            
Balance, end of period at Mar. 31, 2023 3,130,442 $ 58   864,254 2,342,730 $ (118) (77,960) 1,478
Treasury stock, end of period (in shares) at Mar. 31, 2023           14    
Balance, beginning of period (in shares) at Dec. 31, 2022   57,655            
Balance, beginning of period at Dec. 31, 2022 3,003,010 $ 58   847,965 2,248,948 $ (118) (95,321) 1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 319,529              
Balance, end of period (in shares) at Sep. 30, 2023   57,693            
Balance, end of period at Sep. 30, 2023 3,300,018 $ 58   951,086 2,440,043 $ (118) (91,630) 579
Treasury stock, end of period (in shares) at Sep. 30, 2023           14    
Balance, beginning of period (in shares) at Mar. 31, 2023   57,848            
Balance, beginning of period at Mar. 31, 2023 3,130,442 $ 58   864,254 2,342,730 $ (118) (77,960) 1,478
Treasury stock, beginning of period (in shares) at Mar. 31, 2023           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     76          
Equity withheld for employee taxes (in shares)   (21)            
Equity withheld for employee taxes (6,142)     (6,142)        
Stock-based compensation expense 32,449     32,449        
Exercise of stock options (in shares)   170            
Exercise of stock options 4,601     4,601        
Issuance of common stock from employee stock purchase plan (in shares)   77            
Issuance of common stock from employee stock purchase plan 18,466     18,466        
Repurchase of common stock, including excise tax (in shares)   (195)            
Repurchase of common stock, including excise tax (41,437)       (41,437)      
Purchase of subsidiary shares from noncontrolling interest (1,453)     (48)       (1,405)
Contributions to consolidated subsidiary from noncontrolling interest 506             506
Other comprehensive (loss) income 5,875           5,875  
Net income 120,033       120,033      
Balance, end of period (in shares) at Jun. 30, 2023   57,955            
Balance, end of period at Jun. 30, 2023 3,263,340 $ 58   913,580 2,421,326 $ (118) (72,085) 579
Treasury stock, end of period (in shares) at Jun. 30, 2023           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     7          
Equity withheld for employee taxes (in shares)   (2)            
Equity withheld for employee taxes (426)     (426)        
Stock-based compensation expense 34,949     34,949        
Exercise of stock options (in shares)   51            
Exercise of stock options 2,983     2,983        
Repurchase of common stock, including excise tax (in shares)   (318)            
Repurchase of common stock, including excise tax (78,487)       (78,487)      
Other comprehensive (loss) income (19,545)           (19,545)  
Net income 97,204       97,204      
Balance, end of period (in shares) at Sep. 30, 2023   57,693            
Balance, end of period at Sep. 30, 2023 $ 3,300,018 $ 58   951,086 2,440,043 $ (118) (91,630) 579
Treasury stock, end of period (in shares) at Sep. 30, 2023           14    
Balance, beginning of period (in shares) at Dec. 31, 2023 57,787 57,787            
Balance, beginning of period at Dec. 31, 2023 $ 3,471,470 $ 58   1,008,766 2,501,107 $ 0 (39,040) 579
Treasury stock, beginning of period (in shares) at Dec. 31, 2023           0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     261          
Equity withheld for employee taxes (in shares)   (88)            
Equity withheld for employee taxes (26,012)     (26,012)        
Stock-based compensation expense 41,642     41,642        
Exercise of stock options (in shares)   369            
Exercise of stock options 15,251     15,251        
Repurchase of common stock, including excise tax (in shares)   (396)            
Repurchase of common stock, including excise tax (120,593)       (120,593)      
Other comprehensive (loss) income (22,316)           (22,312) (4)
Net income 116,243       116,243      
Balance, end of period (in shares) at Mar. 31, 2024   57,933            
Balance, end of period at Mar. 31, 2024 $ 3,475,685 $ 58   1,039,647 2,496,757 $ 0 (61,352) 575
Treasury stock, end of period (in shares) at Mar. 31, 2024           0    
Balance, beginning of period (in shares) at Dec. 31, 2023 57,787 57,787            
Balance, beginning of period at Dec. 31, 2023 $ 3,471,470 $ 58   1,008,766 2,501,107 $ 0 (39,040) 579
Treasury stock, beginning of period (in shares) at Dec. 31, 2023           0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares) 409              
Net income $ 351,234              
Balance, end of period (in shares) at Sep. 30, 2024 56,708 56,708            
Balance, end of period at Sep. 30, 2024 $ 3,554,629 $ 57   1,129,238 2,465,269 $ 0 (40,517) 582
Treasury stock, end of period (in shares) at Sep. 30, 2024           0    
Balance, beginning of period (in shares) at Mar. 31, 2024   57,933            
Balance, beginning of period at Mar. 31, 2024 3,475,685 $ 58   1,039,647 2,496,757 $ 0 (61,352) 575
Treasury stock, beginning of period (in shares) at Mar. 31, 2024           0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     69          
Equity withheld for employee taxes (in shares)   (18)            
Equity withheld for employee taxes (4,577)     (4,577)        
Stock-based compensation expense 35,285     35,285        
Exercise of stock options (in shares)   23            
Exercise of stock options 1,339     1,339        
Issuance of common stock from employee stock purchase plan (in shares)   85            
Issuance of common stock from employee stock purchase plan 15,717     15,717        
Repurchase of common stock, including excise tax (in shares)   (1,160)            
Repurchase of common stock, including excise tax (216,071) $ (1)     (216,070)      
Contributions to consolidated subsidiary from noncontrolling interest 7             7
Other comprehensive (loss) income (8,071)           (8,071)  
Net income 98,645       98,645      
Balance, end of period (in shares) at Jun. 30, 2024   56,932            
Balance, end of period at Jun. 30, 2024 3,397,959 $ 57   1,087,411 2,379,332 $ 0 (69,423) 582
Treasury stock, end of period (in shares) at Jun. 30, 2024           0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     7          
Equity withheld for employee taxes (in shares)   (3)            
Equity withheld for employee taxes (611)     (611)        
Stock-based compensation expense 41,136     41,136        
Exercise of stock options (in shares)   17            
Exercise of stock options 1,302     1,302        
Repurchase of common stock, including excise tax (in shares)   (245)            
Repurchase of common stock, including excise tax (50,409)       (50,409)      
Other comprehensive (loss) income 28,906           28,906  
Net income $ 136,346       136,346      
Balance, end of period (in shares) at Sep. 30, 2024 56,708 56,708            
Balance, end of period at Sep. 30, 2024 $ 3,554,629 $ 57   $ 1,129,238 $ 2,465,269 $ 0 $ (40,517) $ 582
Treasury stock, end of period (in shares) at Sep. 30, 2024           0